Research & development

OUTLOOK 2026

Transition in full swing: The 4G leadership’s direction and Budget 2026 priorities

With the election over, the focus may be on long-term issues such as climate change and the ageing population

ChemLex has also signed an MOU with the Experimental Drug Development Centre. At the signing ceremony were Sean Lin (seated, left), founder and CEO of the startup, and Prof Damian O’Connell (seated, right), CEO of EDDC.

Chemistry AI startup ChemLex raises US$45 million, sets up global HQ in Singapore

The funds will be used to hire more hardware and software engineers as well as chemists in the city-state

At MWC 2024 in Barcelona, Xiaomi unveiled several products, including its flagship electric vehicle, the SU7 Ultra.
BRANDED CONTENT

S$18 billion spent on R&D: Inside Xiaomi’s push from affordable smartphones to premium EVs

The Chinese tech giant has spent years perfecting its AI-driven ecosystem of connected products as it positions itself as a premium technology leader

Recognition, integration and culture together form the connective tissue that will determine whether Singapore’s research continues to deliver benefits for society.

Building the next chapter of scientific competitiveness

Singapore must make the shift from measuring progress in research outputs or startup numbers to judging success by how science improves lives

At the roundtable on Aug 28 related to the space summit are (from left): Jonathan Hung, executive director of the Office for Space Technology and Industry; Leck Chet Lam, managing director of Experia Events; Sia Kheng Yok, chief executive of the Association of Aerospace Industries (Singapore).

Singapore can support global space industry as a geospatial data hub, says government space office

Rather than competing with other national programmes in the sector, the Republic can complement them with data analytics

Favourable intellectual property regimes, regulatory agility and tax incentives position Asia-Pacific as an attractive destination for global biotech investment, according to a Bain & Company report.

Apac biotech sector could draw capital as investors seek diversification amid US-China tensions

As global biotech strategies shift amid US research funding cuts and geopolitical tensions, markets in the region are gaining ground as innovation hubs

China Medical System expects the secondary listing will help it deepen its presence in South-east Asia and “tap into a new and sophisticated investor base in Singapore”.

Hong Kong-listed China Medical System seeks secondary listing on SGX

The company says it is looking to replicate its success in South-east Asia – building on the proven track record attained in China’s pharmaceutical industry

The company has already been operating an R&D centre in Hanoi since 2020.

US tech giant Qualcomm opens AI R&D centre in Vietnam, its third largest after India, Ireland

This comes after its acquisition of a GenAI unit of Vietnam’s Vingroup in April